Home / Stocks / ORKA

ORKA insider trading

Oruka Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
1
Bought · 24 mo
$1.4M
Buys · last 90 days
0 · $0
Most recent buy
2025-02-27

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-09-01Klein Lawrence Otto
Chief Executive Officer
Sold63,596$91.90$5.8M
2026-08-14Quinlan Paul T
General Counsel
Sold44,523$108.46$4.8M
2026-07-01Fairmount Funds Management LLC
Director · 10% owner
Sold3,553,410$84.43$300.0M
2026-06-12Dambkowski Carl
Director
Sold22,417$70.13$1.6M
2026-05-22Dambkowski Carl
Director
Sold91,765$58.82$5.4M
2025-02-27Koh Bong Y
10% owner
Bought122,882$11.45$1.4M

Most active insider buyers

InsiderRoleBuysTotal bought
Koh Bong Y10% owner1$1.4M

See ORKA on the chart

Every insider buy and sell for ORKA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.